Tocladesine

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameTocladesine
Drug Alias Nametocladesinum托拉地新tocladesina妥拉地新8-Chloro cyclic AMP +[9] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionCyclic AMP agonistsCaspase-3 inhibitors
TargetsCyclic AMPCaspase-3
Therapy Area/IndicationsColorectal NeoplasmsPlasmacytomaMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies IncNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteNorthwestern University
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsPlasmacytomaMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksKEGG